Lusutrombopag
Back to searchMolecule Structure
Scientific Name
Lusutrombopag
Description of the Drug
Lusutrombopag is a medication used to treat thrombocytopenia in patients with chronic liver disease scheduled to have a procedure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13125
http://www.drugbank.ca/drugs/DB13125
Brand Name(s)
Mulpleta, S-888711
Company Owner(s)
Shionogi Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Thrombopoietin receptor | SINGLE PROTEIN | AGONIST | CHEMBL1864 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3062080 | |
| Human Metabolome Database | HMDB0304891 | |
| DrugBank | DB13125 | |
| PubChem: Thomson Pharma | 104171476 | |
| PubChem | 49843517 | |
| Nikkaji | J3.505.027B | |
| BindingDB | 430660 | |
| DrugCentral | 5059 | |
| ChemicalBook | CB13133177 | |
| Guide to Pharmacology | 10032 | |
| rxnorm | LUSUTROMBOPAG | MULPLETA |
| ChEBI | 136051 | |
| ZINC | ZINC000084759273 |
